Overview

Trial of Lenalidomide in Patients With Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT) Type

Status:
Unknown status
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
The activity of monotherapy with Lenalidomide will be evaluated in patients with lymphoma of the mucosa associated lymphoid tissue (MALT).
Phase:
Phase 2
Details
Lead Sponsor:
Medical University of Vienna
Treatments:
Lenalidomide
Thalidomide